Debate Series - Estro-events.org

sCiEnTiFiC proGrAMME
Thursday 10 May 2012
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung
Page 98 PROgRammE & ExhibiTiOn guidE • ESTRO 31
abS. numbER
15:20 > Cutting edge technology: Can we deliver the dose distribution
we plan in brachytherapy?
SPEaKER: D. Baltas (Germany) SP-0104
JOINT SYMPOSIUM
EsTro-EFoMp: shArinG inForMATion And CoMMUniCATion
in rAdiATion onColoGy
lEaRning ObJECTivES:
1. To become familiar with the state of art of Networking in Radiotherapy following
an integrated approach between medical physicist and radiation oncologists in
multidisciplinary approach
2. To understand how to evaluate the critical aspect of network architecture and
transmission standards from the images to treatment and dosimetric verification,
the state of art and future developing of radiation oncology technical framework
following the IHE RO profile and DICOM standard in radiotherapy
3. To appreciate the opportunities and the risks for networking and connectivity in
radiotherapy, taking into account that the International advanced computer
network should be a new future scenario in radiotherapy
14:30 - 15:45 • Room 116
ChaiR: A. Torresin (Italy)
CO-ChaiR: R. Garcia (France)
14:30 > Workflow and data transfer in modern radiotherapy clinics;
taking a step towards paperless network architectures
SPEaKER: M. Enmark (Sweden) SP-0105
14:50 > Improving standards for interoperability in radiation oncology:
DICOM and IHE-RO
SPEaKER: B. Curran (USA) SP-0106
15:10 > Networking and connectivity in radiotherapy:
opportunities and risks
SPEaKER: W. van der Putten (Ireland Republic of) SP-0107
15:25 > International advanced computer network for research
and decision supporting software
SPEaKER: A. Dekker (The Netherlands) SP-0108
Thursday 10 May 2012
abS. numbER
SYMPOSIUM
rAdioThErApy And ThE iMMUnE sysTEM, iMMUnoloGiCAl
AspECTs oF TrEATMEnT rEsponsE To ionisinG rAdiATion
lEaRning ObJECTivES:
1. To understand that radiation acts on the immune system function
2. To understand the contribution of the immune system to normal tissue toxicity
3. To understand the role of the immune system in tumor response to radiation therapy
14:30 - 15:45 • Room 120-121
ChaiR: M.H. Barcellos-Hoff (USA)
CO-ChaiR: A.E. Kiltie (United Kingdom)
14:30 > Radiation-induced changes in anti-tumor immunity
SPEaKER: W. McBride (USA) SP-0109
14:55 > TGF-ß signalling orchestrates late renal toxicity by regulating
the immune response after irradiation
SPEaKER: M. Scharpfenecker (The Netherlands) SP-0110
15:20 > Effects of modulated immune responses on epithelial
radiation effects during fractionated irradiation
SPEaKER: W. Dörr (Germany) SP-0111
SYMPOSIUM
AdApTiVE rAdioThErApy: ChAnGinG ThE prACTiCE
lEaRning ObJECTivES:
1. To understand the rationale of ART and clarify the clinical concept of ART
2. To understand the term ART used in a degenerate way with insight into the logistic
challenges and become familiar with the terminology used to describe the ART
process, to distinguish which processes belong to the disciplines of IGRT of ART
3. To be able to read and understand a flow chart for ART prescription and become
familiar with dose reporting in ART
4. To understand the planning challenges of consecutive phases in ART
5. To understand the uncertainties in dose summation of consecutive plans using rigid
or non-rigid image co-registration methods
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 99
sCiEnTiFiC proGrAMME
eSTRO 31